Literature DB >> 9744457

Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy?

J S Cooper1, T F Pajak, A Forastiere, J Jacobs, K K Fu, K K Ang, G E Laramore, M Al-Sarraf.   

Abstract

BACKGROUND: Local-regional recurrence of disease remains the major obstacle to cure of advanced head and neck cancers.
METHODS: This investigation reviewed data derived from Radiation Therapy Oncology Group (RTOG) protocols #85-03 and #88-24 to identify characteristics of tumors that predicted local-regional recurrence of disease following surgery and postoperative radiotherapy (RT).
RESULTS: The presence of tumor in two or more lymph nodes, and/or extracapsular spread of nodal disease, and/or microscopic-size tumor involvement of the surgical margins of resection imparts a high risk of local-regional (L-R) relapse. Our data also support the hypothesis that, following surgery, the concurrent addition of chemotherapy (CT) to RT may increase the likelihood of L-R control of disease for patients who have these high-risk characteristics.
CONCLUSION: A prospective trial of surgery followed by concurrent RT and CT is warranted for patients who have high-risk characteristics found at surgery.

Entities:  

Mesh:

Year:  1998        PMID: 9744457     DOI: 10.1002/(sici)1097-0347(199810)20:7<588::aid-hed2>3.0.co;2-f

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  34 in total

1.  Nomogram Identifies Age as the Most Important Predictor of Overall Survival in Oral Cavity Squamous Cell Cancer After Primary Surgery.

Authors:  Supriya Gupta; Jennifer Waller; Jimmy Brown; Yolanda Elam; James V Rawson; Darko Pucar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-08-16

2.  Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.

Authors:  Young-Hoon Joo; Ie-Ryung Yoo; Kwang-Jae Cho; Jun-Ook Park; In-Chul Nam; Chung-Soo Kim; Min-Sik Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-15       Impact factor: 2.503

3.  Chromosomal changes characterize head and neck cancer with poor prognosis.

Authors:  Verena L Bauer; Herbert Braselmann; Michael Henke; Dominik Mattern; Axel Walch; Kristian Unger; Michael Baudis; Silke Lassmann; Reinhard Huber; Johannes Wienberg; Martin Werner; Horst F Zitzelsberger
Journal:  J Mol Med (Berl)       Date:  2008-09-23       Impact factor: 4.599

Review 4.  Cancer of the gingiva.

Authors:  Rusana Bark; Claes Mercke; Eva Munck-Wikland; Natalie Ann Wisniewski; Lalle Hammarstedt-Nordenvall
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-04       Impact factor: 2.503

5.  Is postoperative adjuvant chemoradiotherapy necessary for high-risk oropharyngeal squamous cell carcinoma?

Authors:  Tomoya Yokota; Tetsuro Onitsuka; Kimihide Kusafuka; Hirofumi Ogawa; Yusuke Onozawa; Masahiro Nakagawa; Yoshiyuki Iida; Tomoyuki Kamijo; Tetsuo Nishimura; Takashi Nakajima; Narikazu Boku; Hirofumi Yasui
Journal:  Int J Clin Oncol       Date:  2013-03-05       Impact factor: 3.402

6.  Improved survival in HPV/p16-positive oropharyngeal cancer patients treated with postoperative radiotherapy.

Authors:  Gregor Heiduschka; Anja Grah; Felicitas Oberndorfer; Lorenz Kadletz; Gabriela Altorjai; Gabriela Kornek; Fritz Wrba; Dietmar Thurnher; Edgar Selzer
Journal:  Strahlenther Onkol       Date:  2014-09-25       Impact factor: 3.621

7.  Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.

Authors:  Jay S Cooper; Qiang Zhang; Thomas F Pajak; Arlene A Forastiere; John Jacobs; Scott B Saxman; Julie A Kish; Harold E Kim; Anthony J Cmelak; Marvin Rotman; Robert Lustig; John F Ensley; Wade Thorstad; Christopher J Schultz; Sue S Yom; K Kian Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-30       Impact factor: 7.038

8.  Histological assessment of cervical lymph node identifies patients with head and neck squamous cell carcinoma (HNSCC): who would benefit from chemoradiation after surgery?

Authors:  Xiao Chloe Wan; Ann Marie Egloff; Jonas Johnson
Journal:  Laryngoscope       Date:  2012-10-11       Impact factor: 3.325

Review 9.  [Radiotherapy, chemotherapy and target therapy for treatment of head and neck cancer : new developments].

Authors:  R Knecht
Journal:  HNO       Date:  2009-05       Impact factor: 1.284

10.  Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.

Authors:  Jason T Rich; Simon Milov; James S Lewis; Wade L Thorstad; Douglas R Adkins; Bruce H Haughey
Journal:  Laryngoscope       Date:  2009-09       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.